Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016
- PMID: 28794077
- DOI: 10.1136/annrheumdis-2017-211663
Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016
Erratum in
-
Correction: Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016.Ann Rheum Dis. 2018 Mar;77(3):472. doi: 10.1136/annrheumdis-2017-211663corr1. Ann Rheum Dis. 2018. PMID: 29440018 No abstract available.
Abstract
Objective: To determine trends in survival among adult and paediatric patients with systemic lupus erythematosus (SLE) from 1950 to the present.
Methods: We performed a systematic literature review to identify all published cohort studies on survival in patients with SLE. We used Bayesian methods to derive pooled survival estimates separately for adult and paediatric patients, as well as for studies from high-income countries and low/middle-income countries. We pooled contemporaneous studies to obtain trends in survival over time. We also examined trends in major causes of death.
Results: We identified 125 studies of adult patients and 51 studies of paediatric patients. Among adults, survival improved gradually from the 1950s to the mid-1990s in both high-income and low/middle-income countries, after which survival plateaued. In 2008-2016, the 5-year, 10-year and 15-year pooled survival estimates in adults from high-income countries were 0.95, 0.89 and 0.82, and in low/middle-income countries were 0.92, 0.85 and 0.79, respectively. Among children, in 2008-2016, the 5-year and 10-year pooled survival estimates from high-income countries were 0.99 and 0.97, while in low/middle-income countries were 0.85 and 0.79, respectively. The proportion of deaths due to SLE decreased over time in studies of adults and among children from high-income countries.
Conclusions: After a period of major improvement, survival in SLE has plateaued since the mid-1990s. In high-income countries, 5-year survival exceeds 0.95 in both adults and children. In low/middle-income countries, 5-year and 10-year survival was lower among children than adults.
Keywords: adult; mortality; pediatric; survival; systemic lupus erythematosus.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis.Rheumatol Int. 2022 Dec;42(12):2097-2107. doi: 10.1007/s00296-022-05183-4. Epub 2022 Aug 25. Rheumatol Int. 2022. PMID: 36006459 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD014963. doi: 10.1002/14651858.CD014963.pub2. Cochrane Database Syst Rev. 2022. PMID: 36385229 Free PMC article.
-
Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low- and middle-income countries.Cochrane Database Syst Rev. 2017 Nov 15;11(11):CD011135. doi: 10.1002/14651858.CD011135.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2022 Mar 29;3:CD011135. doi: 10.1002/14651858.CD011135.pub3. PMID: 29139110 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
Cited by
-
Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study.Arthritis Res Ther. 2021 Mar 10;23(1):79. doi: 10.1186/s13075-021-02466-2. Arthritis Res Ther. 2021. PMID: 33691746 Free PMC article.
-
Management and outcomes in children with lupus nephritis in the developing countries.Pediatr Nephrol. 2023 Apr;38(4):987-1000. doi: 10.1007/s00467-022-05769-x. Epub 2022 Oct 18. Pediatr Nephrol. 2023. PMID: 36255555 Review.
-
Renal C4d is a potential biomarker of disease activity and severity in pediatric lupus nephritis patients.Front Pediatr. 2023 Jun 1;11:1193917. doi: 10.3389/fped.2023.1193917. eCollection 2023. Front Pediatr. 2023. PMID: 37325343 Free PMC article.
-
International cohort of 382 children with lupus nephritis - presentation, treatment and outcome at 24 months.Pediatr Nephrol. 2023 Nov;38(11):3699-3709. doi: 10.1007/s00467-023-06018-5. Epub 2023 May 24. Pediatr Nephrol. 2023. PMID: 37221349
-
The neutrophil-to-lymphocyte ratio as a surrogate marker for disease activity in systemic lupus erythematosus: a correlation study using the SLE-DAS.Ther Adv Musculoskelet Dis. 2025 Jun 19;17:1759720X251347272. doi: 10.1177/1759720X251347272. eCollection 2025. Ther Adv Musculoskelet Dis. 2025. PMID: 40547600 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical